Jarred Shein joins us to talk digital health. Jarred has invested in digital health at MH Carnegie and Qure, an Israeli based VC fund.
0:20 - Introducing Jarred
1:00 - Jarred's education and background.
1:45 - Jarred's studies of nanotechnology, specifically biochemistry
2:30 - Jarred's thesis on biosensor devices and how it relates to Startrek
3:55 - End of university job with Macromatix, completely unrelated to biochemistry
5:10 - The early opportunity to pick up distressed medical device assets
6:00 - Australia's strong position in the world and relatively painless COVID-19 experience make it a great place for global healthcare
8:10 - Australia's unfortunate lack of a biochemistry talent pool
9:30 - Australia's amazing history of medical device companies, including Cochlear and Resmed
10:30 - The opportunity to invest in the digital health space in Australia
11:40 - Deep dive into Resmed (RMD:ASX) and its successful pivot to health data revenue
14:40 - The benefits of living and doing business in Australia
16:33 - The rise and rise of telehealth services, silencing industry doubters
18:50 - 'Ageing in Place' (getting older comfortably in the environment that you are in) is a really interesting growth space
21:25 - 'Digital Therapeutics' (clinically relevant personal solutions) is another compelling growth area (e.g. Propeller Health - a recent Resmed acquisition)
25:00 - Discussion of Click Therapeutics (digital therapeutics solutions for mental health issues)
26:55 - What happens when the 20 year patent life timer ends?
27:50 - Jarred's thoughts on Livongo (NASDAQ:LVGO), a Frazis Capital position
30:30 - Successful US healthcare business models rely on the US health insurance system
32:00 - The merger between Teladoc (NYSE:TDOC) and LVGO
34:00 - There should be a very tight communication channel between primary care and chronic disease management
35:25 - Do you book a telehealth consultation based on Brand? Doctor? Or Price?
37:30 - Today's best opportunities in digital health, both listed and unlisted
38:50 - Missed opportunity in American Well (NYSE:AMWL), a hot recent digital health IPO
40:10 - Lots of opportunities in the private space for digital health
40:45 - Early stage Australian digital health companies can only access capital by going public
41:35 - Jarred discusses a compelling Australian microcap digital health opportunity, Hera Med (ASX:HMD)
43:40 - Jarred introduces an interesting QLD telehealth service provider called Medicine, providing remote primary care services
45:00 - Some problems within the digital health industry - access to capital and talent, commercialising technology
